Incense, Indian uses, benefits and dosage | DISCOUNT CODE !

Scientific name: Boswellia serrata Roxb.
Common names): Dhup, Indian incense, Indian oliban, Salai guggal

Medically reviewed by Last updated on Jul 1, 2019.

Clinical overview


The oleoresin gum of B. serrata is traditionally used for its anti-inflammatory effects under conditions such as asthma, osteoarthritis, rheumatoid arthritis, colitis and irritable bowel syndrome. It has also been used for the treatment of diabetes, urinary disorders, dermatological conditions and kidney disorders. Boswellic acids have demonstrated immunomodulatory, antiproliferative, cytotoxic and antimicrobial effects; However, there are no adequate clinical trials to support any of the uses.


Administration with high fat foods may increase plasma concentrations of B. serrata. Asthma: 300 to 400 mg of an extract (containing 60% of boswellic acids) 3 times a day. In one test, 300 mg 3 times a day of powdered gum resin capsules (compound S) or 400 mg 3 times a day of an extract (titrated at 37.5% acid) were used. Boswellic per dose). Inflammatory conditions: 300 to 400 mg of a B. serrata extract (containing 60% of boswellic acids) 3 times a day were used in a clinical trial in patients with knee osteoarthritis. Two capsules of Articulin-F (contains: B. serrata, Withania somnifera, Turmeric longa, zinc complex) 3 times a day; or supplementation with Casperome (150 mg of boswellic acids) 3 times a day has been used for inflammatory conditions such as osteoarthritis and rheumatoid arthritis. Ulcerative colitis: 350 to 400 mg 3 times a day.


Hypersensitivity to B. serrata.

Pregnancy / breastfeeding

Avoid using. Information regarding safety and effectiveness during pregnancy and breastfeeding is lacking.

The interactions

Cytochrome P450 (CYP-450) substrates 1A2, 2C8, 2C9, 2C19, 2D6 and 3A4: When analyzed by mass spectrometry by liquid chromatography, incense derived from B. serrata demonstrated inhibition of CYP1A2, 2C8, 2C9, 2C19, 2D6 and 3A4 enzymes. Therefore, caution is required when using B. serrata with drugs that are substrates for these isoenzymes. Substrates for P-glycoprotein (P-gp): The data suggest that the extract of B. serrata and the major boswellic acids could be potent inhibitors of P-gp via the modulation of gastrointestinal transport activity but not at the barrier blood brain. Therefore, the concomitant administration of B. serrata may have an impact on drugs that depend on the transport of P-gp across the gastrointestinal membrane. warfarin: According to 2 case reports, concomitant administration of warfarin and B. serrata could increase International Normalized Ratio (INR) rates. The interaction can be attributed to the inhibition of lipoxygenase and the interference of COX-1 by B. serrata. In addition, B. serrata may inhibit CYP2C19, 3A4 and 2C9, which are involved in the metabolism of warfarin. The use of B. serrata in patients receiving warfarin is not recommended.

Side effects

Cases of diarrhea, abdominal pain and nausea have been reported.


No data.

Scientific family


The family of Burseraceae trees and shrubs comprises 18 genera and more than 540 species, which grow mainly in the tropical regions of India (B. serrata), North Africa (Boswellia carteri, Boswellia frereana) and in the peninsula Arabian (Boswellia sacra). Most species contain resin ducts in the bark, which produce the products of myrrh and incense.1, 2 B. serrata is a branched tree that grows on dry and hilly areas in most of India and can reach 3.7 m in height.3 the bark is cut off, the aromatic balm or gum resin oozes and is used for medicinal purposes.4 The semi- resin Solid is usually harvested every summer and every autumn and is collected in bamboo baskets where it stays about 1 month. during which the fluid is drained. The residue, which is semi-solid to solid, is the part of the gum resin that cures slowly and is eventually broken into smaller pieces. The tree can produce a quality product for a period of 3 years, after which it must be allowed to rest before being harvested again.5 Oleoresin contains oils, terpenoids and of the gum.6


It is believed that the Indian incense tree is related to the tree of the Bible that gave the incense given by the wise men as a gift to the baby Jesus. In Ayurvedic medicine in India, different parts of the tree have been used for asthma, rheumatism, dysentery, skin conditions, ulcers, blood purification, bronchi and wound treatment. 4 In Ayurvedic texts, B. serrata is addressed under the name "Gajabhakshya". , "meaning that it was consumed by elephants.7 Incense is also used to perfume clothes, hair and coins.It was used in ancient Egypt as an ingredient in liquids. Embalming for mummification.It has always been burned during religious and / or spiritual ceremonies and would produce a psychoactive substance.8 In 2002, the European Medicines Agency classified the resin gum extract B. serrata as an orphan drug9.


B. serrata contains oils, terpenoids, sugars and volatile oils. Four pentacyclic triterpenes are also present: beta-boswellic acid, acetyl-beta-boswellic acid, 11-keto-beta-boswellic acid, and acetyl-11-keto acid. -beta-boswellic.3, 6, 10, 11

Uses and pharmacology

Anticancer effects

Animal and in vitro data

In an in vitro study, acetyl-keto-beta-boswellic acid and keto-beta-boswellic acid exerted antiproliferative and apoptotic effects on human HT-29 colon cancer cells.12 Similarly, , apoptotic effects of boswellic acid acetate were observed in myeloid leukemia cells. Cytotoxic effects were observed with acetyl-11-keto-beta-boswellic acid in the cell lines of glioblastoma and leukemia.14

In a mouse model, 50 to 200 mg / kg of acetyl-11-keto-beta-boswellic acid, administered orally, inhibited the growth of colorectal cancer cells in a dose-dependent manner, with a subsequent reduction in volume. tumor; it was also associated with reduced ascites and metastases to the liver, lungs and spleen.

An extract of B. serrata resulted in loss of viability and inhibition of the proliferation of 5 leukemia cell lines and 2 brain tumor lines in a dose-dependent manner.

Clinical data

In a study of patients with primary or secondary malignant brain tumors, a greater than 75% reduction in cerebral edema was observed in 60% of patients receiving radiotherapy with 4,200 mg of B. serrata per day compared to 26% of patients receiving radiotherapy alone (P= 0.023) .17

In a case study of a 39-year-old woman with metastases to the breast cancer brain, a CT scan showed complete disappearance of brain metastases after administration of 2400 mg of B. serrata per day for 10 weeks. The patient continued this treatment for 4 years without any new sign of cerebral involvement; however, she developed skeletal metastases.18

In a study of 19 children and adolescents with intracranial tumors, palliative treatment with H15, a herbal agent derived from B. serrata gum resin, resulted in various improvements in general health, symptoms and neurological (ataxia, paresis) and muscle strength; a cachectic patient gained weight.19

In a study of 12 patients with brain tumors and progressive edema associated, H15 1,200 mg 3 times daily reduced edema in 2 out of 7 patients with glioblastoma and in 3 out of 5 patients with leukoencephalopathy . In general, the maximum response to treatment was noted within 4 weeks of starting treatment and no further reduction was seen with continued treatment.

Antidiabetic effects

Animal and in vitro data

In a study in diabetic rats, administration of B. serrata (a dose of 200 mg / kg was found to be most effective) resulted in a significant reduction in blood glucose and hemoglobin levels. AT1 C levels after 17 days (P≤0.01) .21 An extract of B. serrata also greatly attenuated the effects in a mouse model of induced diabetes.22

Clinical data

In a study of 56 diabetic patients, 250 mg of B. serrata twice daily for 8 weeks had no effect on glucose or lipid levels compared with placebo23. Additional studies on the effects of B. serrata extract on late autoimmune diabetes are needed; a case report noted a clinical improvement and a decrease in IA2 antibodies in a patient treated with B. serrata extract.24

Anti-inflammatory effects

In vitro, boswellic acids are specific inhibitors of 5-lipoxygenase (5-LO), a key enzyme in the biosynthesis of leukotrienes. Leukotrienes are biochemicals in the body that maintain inflammation. Of the 4 boswellic acids, acetyl-11-keto-beta-boswellic acid is the most potent inhibitor of 5-LO11 and appears to act directly on 5-LO at a selective site for pentacyclic triterpenes25. Boswellic acids have been traditionally used inflammatory conditions such as arthritis, tendinitis and bursitis.4, 10

Animal and in vitro data

The anti-inflammatory activity of B. serrata has been studied in animals.10 The plant extract has a marked anti-inflammatory and anti-arthritic action in the rat, without significant adverse reactions26. In a report evaluating the inhibition of leukotriene synthesis by boswellic acid (via -LO), no effect on 12-lipoxygenase, cyclooxygenase or arachidonic acid peroxidation by iron and ascorbate has been observed, suggesting that boswellic acids are non-redox inhibitors of leukotriene synthesis.27 Similar results have been observed in rat peritoneal neutrophils.28, 29

In a study on mice, B. serrata was found to be ineffective in preventing weight loss or mucosal damage caused by colitis. No improvement in mortality or colon histology was noted.30

In a rat study, boswellic acids showed antiulcerogenic effects in various models of ulceration31. In addition, B. serrata exerted anti-inflammatory and antioxidant effects in an experimental model of acute colitis in rats32.

Clinical data

GI conditions

B. serrata appears to have a benefit in ulcerative colitis because of its ability to inhibit 5-LO. In a clinical trial, patients treated with B. serrata gum resin (350 mg three times daily) for 6 weeks showed improvement in ulcerative colitis parameters (stool properties, histopathology, rectal biopsies, blood test) compared to patients treated with sulfasalazine (1 g 3 times daily). The remission was 82% with the resin and 75% with the sulfasalazine.33 In a study in patients with ulcerative colitis in the phase of symptomatic remission, administration of 250 mg / day of Casperoma, a system of lecithin-based administration for B. serrata designed to improve bioavailability, had a beneficial effect on bowel pain parameters (ie, obvious and occult blood in feces, intestinal defecation, cramps, diarrhea, malaise , anemia, rectal involvement, number of white blood cells, need for additional medication or medical care) .34

A meta-analysis identified 7 placebo-controlled clinical trials evaluating the efficacy and tolerability of herbal drugs in inflammatory bowel disease. Based on 2 studies (N = 113) evaluating B. serrata in patients with Crohn's disease or collagenous colitis, a significant result was identified for the induction of clinical remission (relative risk , 2.34) .35 However, a relevant systematic review of randomized trials revealed B. serrata to be ineffective for the treatment of collagenous colitis; the authors note, however, that the studies reviewed may have been underperforming to detect a difference. One trial examined (Madisch et al.) Included 31 patients, of which 26 were included in per protocol analysis. After 6 weeks of oral administration of 400 mg of B. serrata 3 times daily, more patients in the treated group were in remission compared with those in the placebo group. The difference was significant in the per-protocol group compared with placebo (P= 0.04) but not in the intention-to-treat group (P= 0.25), indicating a possible defect in the design of the study.37, 38

In a randomized controlled trial comparing the efficacy and safety of the extract of B. serrata (H15) to mesalazine in patients with active Crohn's disease, B. serrata was found to be active. is revealed not inferior to mesalazine39. In another trial, B. serrata administered for one year was evaluated for use in maintaining remission in patients with Crohn's disease. The study was interrupted early because of a high dropout rate and low patient recruitment. The data analyzed did not reveal any difference between treatment and placebo.40

In a study of 30 patients with chronic colitis, patients received either 300 mg of B. serrata 3 times daily or 1 g of sulfasalazine 3 times daily for 6 weeks. Among patients receiving B. serrata, 90% reported improvement in at least one parameter such as stool properties, histopathology or microscopy, and 70% were in remission. With sulfasalazine, 60% showed improvement and 40% were in remission41.


In a double-blind, randomized, clinical study in high school women with gingivitis, the B. serrata extract exerted anti-inflammatory effects.

Osteoarthritis and other pain

In a double-blind, randomized, cross-over trial of healthy adult volunteers (N = 12), the threshold of pain and tolerance were significantly increased with the administration of a single oral dose of 125 mg B. serrata (2 capsules) compared with placebo. Using a mechanical pain model, subjects experienced a significant increase in mean pain threshold strength and time from baseline, 2 hours and 3 hours after drug administration, compared to placebo (P<0.05); Mean strength and time with B. serrata at the pain threshold were also statistically significant at 3 hours compared with baseline (P<0.05). In addition, the mean pain tolerance time and force were significantly increased at all three times (ie, 1, 2, and 3 hours after drug administration) compared with baseline values ​​(P<0.05). The mean percentage change in strength and pain tolerance time from baseline was also significantly increased at all times compared to placebo (P≤0.01 .43

In a Cochrane review of combined data from 2 high-quality studies of a small number of patients (N = 85), a 100 mg / day B. serrata extract administered for 90 days improved the symptoms of the disease. ; osteoarthritis. Specifically, B. serrata reduced the mean visual analogue scale score (VAS) by 17 points compared to placebo, a number needed to treat an additional benefit of 2. Patients receiving B. serrata reported an improvement in physical function (8 (point improvement) versus placebo.44

In a randomized, double-blind, placebo-controlled crossover study of 42 osteoarthritis patients, B. serrata in a herbomineral combination was compared to placebo. B. serrata decreased pain and disability scores, but the radiological assessment showed no change45. Similarly, in a crossover study involving 30 patients with osteoarthritis of the knee, B. serrata 1 g / day for 8 weeks improved knee pain, knee flexion, walking distance and swelling46. Compared to valdecoxib, patients treated with B. serrata extract for knee osteoarthritis showed improvement in pain, stiffness and difficulties in performing activities after 2 months of treatment; these effects persisted until 1 month after stopping treatment. Valdecoxib also managed to improve these parameters after one month of treatment, but its effects persisted only as long as treatment was continued47.

New products made from B. serrata have been tested in clinical studies. Aflapine, which is derived from B. serrata gum resin, improves pain and physical function scores in patients with osteoarthritis of the knee at a dose of 100 mg / day for 30 days. . Similar results have been observed in patients with osteoarthritis of the knee. receiving 5-loxine (extract of B. serrata enriched with 30% of 3-O-acetyl-11-keto-beta-boswellic acid) from 250 to 500 mg / day for 90 days, with improvement noted as early as 7 days after the initiation of the In a study of 52 male rugby patients with knee pain without osteoarthritis, Casperoma (derived from B. serrata extract) administered at 500 mg / day for 5 days, followed by 250 mg / day for 23 days, at effort, walking distance without pain, joint effusion, structural damage, thermal imaging and VAS pain scores.

An older review of the literature suggests a potential benefit of B. serrata gum resin in the treatment of rheumatoid arthritis51. In a small study of 4 patients with chronic cluster headaches receiving B. serrata, long-term (mean, 15 months) analgesic effects were observed in 3 patients and transient analgesic effects (mean, 6 months). ) were observed in 1 patient.52

Antimicrobial effects

Animal and in vitro data

Acetyl-11-keto-beta-boswellic acid exerts antibacterial effects against Staphylococcus aureus in an in vitro model.

In an in vitro study, B. serrata was found to have antiprotozoal activity against Trypanosoma brucei and Plasmodium falciparum54.

In a study evaluating the antimicrobial activity of various commercially available essential oils, B. serrata essential oil exerted an antimicrobial activity against Trichophyton spp. It has also been found to have a synergistic effect with azoles against azole-resistant Candida albicans. Thus, B. serrata can be useful in the treatment of infections of the skin, scalp and nails.

Asthmatic effects

Boswellic acids may be beneficial in the treatment of asthma due to the inhibition of leukotriene biosynthesis by the inhibition of 5-LO56.

Clinical data

A systematic review and meta-analysis conducted in 2010 evaluated several complementary substitutes, including boswellic acids, for asthma management. Given the small size of the samples, the short duration of studies and the poor methodology, among other limitations, it is difficult to make a recommendation regarding the use of boswellic acids for the management of asthma. . Individual studies have identified differences in peak expiratory flow and forced vital capacity.57

In a small, double-blind, placebo-controlled clinical trial, administration of 300 mg of B. serrata gum resin 3 times daily for 6 weeks improved physical symptoms such as dyspnea and rhonchi, number of attacks and spirometry measurements in 70% of cases. compared with 27% of those receiving placebo.58

Dermatological effects

Clinical data

In a randomized, double-blind, placebo-controlled study, the effects of a cream containing 0.5% of boswellic acids were evaluated in 15 women with photo-treated skin. The patients received 2 tubes, one containing boswellic acids and the other containing just an emollient. Patients were asked to apply 1 cream on each half of the face once a day for 30 days. The application of boswellic acid cream was associated with improvements in Dover's overall score for photoaging, tactile roughness, fine lines and elasticity, as well as a reduction in Excretion of sebum59, 60.

A randomized, placebo – controlled, parallel – group study of 114 women undergoing adjuvant radiotherapy after breast cancer surgery evaluated the safety and efficacy of a cream containing breast cancer. boswellic acid (Bosexil) compared to a basic cream for the prevention of dermatological effects induced by radiation. The cream was applied twice daily on radiation days immediately after radiation. The application of the boswellic acid cream was associated with reduced grade erythema, with visual intensity being described as "intense" in a greater proportion of those receiving a base cream (49%) per day. compared to those receiving a cream containing boswellic acid (22%; P= 0.009). In addition, the use of topical steroids has been reduced with the use of cream containing boswellic acid.

In a randomized, double-blind, placebo-controlled study in patients with psoriasis, administration of Bosexil twice daily for 30 days improved dander in 70% of cases and erythema in 50 % of cases. In patients with eczema, 60% reported an improvement in itching and 60%, an improvement in erythema.62

Immunomodulatory activity

Animal and in vitro data

The stabilizing activity of mast cells has been demonstrated with a B. serrata gum resin extract in a murine model63. In an immunological study, it was shown that boswellic acids possessed anticomplementary activity via the inhibition of C3-convertase.64 C3-convertase is involved in the production of anaphylatoxin.

Renal effects

Animal data

In a mouse model, B. serrata partially protected the kidneys in cases of acute and chronic renal failure. Gum arabic and ginger had more promising results than B. serrata66.

Clinical data

In a study of 16 patients with chronic non-dialyzed renal failure, the combination of B. serrata and C. longa, administered for 8 weeks, improved interleukin-6 levels; however, no difference was observed between other markers, such as tumor necrosis factor alpha, glutathione peroxidase and serum C-reactive protein.

Urinary effects

B. serrata may be useful in the treatment of stress incontinence because of its astringent properties and its ability to tone muscles.68

Clinical data

In the context of a randomized, single-blind, placebo-controlled prospective clinical trial in women of reproductive age with stress incontinence, the combination of B. serrata and Cyperus scariosus (1 g of each powder twice a day for 8 weeks) in addition to the pelvic floor muscle training was associated with a 23% improvement over the reduction in stress incontinence versus pelvic floor muscle training alone (60% cure rate vs. 36.67%; P= 0.035) .68

In a randomized study in men with chronic prostatitis, antibiotics associated with Proxelan suppositories (a herbal mixture containing Boswellia) improved patients' symptoms, but did not alter microbiological results compared to patients with chronic prostatitis. antibiotics used alone. The exact species of Boswellia used is not clear.69

Other uses

In an in vitro study, beta-boswellic acid exerted protective effects on endothelial function induced by blood stasis by increasing the phosphorylation of the enzyme nitric oxide synthase.70

In a fully allogenic mouse heart transplant model, boswellic acid prolonged the survival time of the graft71.


Administration with high fat foods may increase plasma concentrations of B. serrata.72


300 to 400 mg of an extract (containing 60% of boswellic acids) 3 times a day3. In one trial, 300 mg 3 times a day of powdered gum resin capsules (S-Compound) or 400 mg 3 times daily of a 37.5% boswellic acid extract per dose) was utilisé.8

Inflammatory conditions

300 to 400 mg of B. serrata extract (containing 60% of boswellic acids) 3 times a day were used in a clinical trial in patients with knee osteoarthritis3.

Two capsules of Articulin-F (contains: B. serrata, W. somnifera, C. longa, zinc complex) 3 times daily8; or supplementation with Casperome (150 mg of boswellic acids) 3 times a day has been used for inflammatory conditions such as osteoarthritis and rheumatoid arthritis.

Ulcerative colitis

350 to 400 mg 3 times a day.8

Pregnancy / breastfeeding

Avoid using. Information regarding safety and effectiveness during pregnancy and breastfeeding is lacking. Reports from Indian literature suggest that B. serrata resin could induce abortion.8

The interactions

Substrates of CYP1A2, 2C8, 2C9, 2C19, 2D6 and 3A4

When analyzed by mass spectrometry by liquid chromatography, incense derived from B. serrata demonstrated inhibition of CYP1A2, 2C8, 2C9, 2C19, 2D6 and 3A4 enzymes. Therefore, caution is required when using B. serrata with drugs that are substrates for these isoenzymes.2

Substrates for P-gp

The data suggest that the extract of B. serrata and the major boswellic acids could be potent inhibitors of P-gp via modulation of gastrointestinal transport activity but not at the level of the blood-brain barrier73. Therefore, drugs that depend on the transport of P-gp Co-administration of B. serrata may affect the gastrointestinal membrane.


According to 2 case reports, concomitant administration of warfarin and B. serrata could increase INR rates. The interaction can be attributed to the inhibition of lipoxygenase and the interference of COX-1 by B. serrata. In addition, B. serrata may inhibit CYP2C19, 3A4 and 2C9, which are involved in the metabolism of warfarin. The use of B. serrata in patients treated with warfarin is not recommended74.

Side effects

B. serrata is generally well tolerated. It has been associated with mild gastrointestinal disturbances such as nausea, abdominal pain, diarrhea, loss of appetite and acid reflux. 8, 75, 76, 77 Hepatotoxic effects have been reported in a study in mice.17 A case report describes the development of dermatitis contact in a 28-year-old woman who used a naturopathic cream containing B. serrata for the treatment of second-degree burns. Topical and systemic corticosteroids were needed to treat his contact dermatitis, which included a local cutaneous reaction with the development of bubbles. A patch test gave positive results when B. serrata was tested. A few months later, the patient developed contact dermatitis after applying the same cream to her husband.6


The median lethal dose (DL50) de B. serrata a été déterminée comme étant supérieure à 2 g / kg.3,7,40,40,78 Chez le rat, la DL aiguë par voie orale50 d’aflapine, une composition synergique dérivée de résine de gomme de B. serrata, était de 5 g / kg, et la DL cutanée aiguë50 La concentration d’aflapine était de 2 g / kg79. Un produit combiné contenant B. serrata, Zingiber officinale, C. longa et W. somnifera n’a été associé à aucune toxicité chez le rat recevant une dose de 10 g / kg.80


1. Ghazanfar S. Manuel des plantes médicinales arabes. Boca Raton, FL: CRC Press; 1994: 62,2. Frank A, Unger M. Analyse de l&#39;encens de divers Boswellia espèces ayant une activité inhibitrice sur les enzymes du cytochrome P450 métabolisant le médicament humain, utilisant la spectrométrie de masse par chromatographie en phase liquide après extraction en ligne automatisée. J Chromatogr A. 2006; 1112 (1-2): 255-262.163643383. Boswellia serrata. Altern Med Rev. 2008; 13 (2): 165-167,185903524. Broadhurst C, et al. Chimie à base de plantes. Herbes pour la santé. 1998; janvier / février: 20,5. Siddiqui MZ. Boswellia serrata, un agent anti-inflammatoire potentiel: un aperçu. Indian J Pharm Sci. 2011; 73 (3): 255-261,224575476. Acebo E, Juge Ratón, Sautúa S., Eizaguirre X, Trébol I, Pérez JL. Dermite allergique de contact de Boswellia serrata extraire dans une crème naturopathique. Dermatite de contact. 2004; 51 (2): 91-92,153738537. Khan MA, Ali R, R Parveen, AK Najmi et Ahmad S. Données pharmacologiques confirmant les propriétés cytotoxiques et antitumorales des acides boswelliques Boswellia serrata. J Ethnopharmacol. 2016; 191: 315-323,273465658. Basch E, Boon H. Davies-Heerema T. et al. Boswellia: une revue systématique basée sur des preuves par Natural Natural Research Collaboration. J Herb Pharmacother. 2004; 4 (3): 63-83,158294709. Triantafyllidi A, Xanthos T, Papalois A, Triantafillidis JK. Phytothérapie et phytothérapie chez les patients atteints de maladie inflammatoire de l’intestin. Ann Gastroenterol. 2015; 28 (2): 210-220,2583066110. Bruneton J. Pharmacognosie, phytochimie, plantes médicinales. Paris, France: Pub Lavoisier; 1995: 607-608.11. Al-Yasiry AR, Kiczorowska B. Encens – propriétés thérapeutiques. Postepy Hig Med Dosw (En ligne). 2016; 70: 380-391,2711711412. Liu JJ, Nilsson A, S Oredsson, V Badmaev, Zhao WZ, RD Duan. Les acides boswelliques déclenchent l&#39;apoptose via une voie dépendante de l&#39;activation de la caspase-8 mais indépendante de l&#39;interaction Fas / Fas ligand dans les cellules HT-29 du cancer du côlon. Cancérogenèse. 2002; 23 (12): 2087-2093,1250793213. Xia L, Chen D, Han R, Fang Q, Waxman S, Jing Y. L&#39;acétate d&#39;acide bosswellique induit l&#39;apoptose par des voies médiées par la caspase dans les cellules de la leucémie myéloïde. Cancer de Mol. 2005; 4 (3): 381-388,1576754714. Park YS, Lee JH, Bondar J, Harwalkar JA, Safayhi H, Golubic M. Action cytotoxique de l&#39;acide acétyl-11-céto-bêta-boswellique (AKBA) sur les cellules de méningiome. Planta Med. 2002; 68 (5): 397-401,1205831315. Yadav VR, Prasad S, Sung B, et al. L&#39;acide boswellique inhibe la croissance et les métastases du cancer colorectal humain chez un modèle de souris orthotopique en régulant négativement les biomarqueurs inflammatoires, proliférants, invasifs et angiogéniques. Cancer Int J. 2012; 130 (9): 2176-2184.2170203716. Hostanska K, Daum G, Saller R. Activité cytostatique et induisant l&#39;apoptose des acides boswelliques vis-à-vis des lignées de cellules malignes in vitro. Anticancer Res. 2002; 22 (5): 2853-2862,1253000917. Kirste S, Treier M, Wehrle SJ et al. Boswellia serrata agit sur l&#39;œdème cérébral chez des patients irradiés pour une tumeur au cerveau: étude pilote prospective, randomisée, à double insu contrôlée contre placebo. Cancer. 2011; 117 (16): 3788-3795,2128753818. Flavin DF. Un inhibiteur de lipoxygénase dans les métastases cérébrales du cancer du sein. J Neurooncol. 2007; 82 (1): 91-93.1700151719. Janssen G, U Bode, H Breu, Dohrn B, Englebrecht V, Göbel U. Acides boswelliques dans le traitement palliatif des enfants atteints de tumeurs cérébrales évolutives ou en rechute. Klin Padiatr. 2000; 212 (4): 189-195.1099454920. Streffer JR, M Bitzer, Schabet M, J Dichgans, Weller M. Réponse de l&#39;oedème cérébral associé à la radiochimiothérapie à un agent phytothérapeutique, H15. Neurologie. 2001; 56 (9): 1219-1221,134269221. Azemi ME, Namjoyan F, Khodayar MJ, Ahmadpour F, Darvish Padok A, Panahi M. La capacité antioxydante et l&#39;effet antidiabétique de Boswellia serrata extrait aqueux de triana et de planch chez des rats femelles diabétiques fertiles et les effets possibles de la reproduction et des modifications histologiques du foie et des reins. Jundishapur J Nat Pharm Prod. 2012; 7 (4): 168-175.2462417722. Shehata AM, Quintanilla-Fend L, Bettio S, Singh CB, Ammon HP. Prévention du diabète à multiples doses de streptozotocine (MLD-STZ) chez la souris par un extrait de résine de gomme de Boswellia serrata (ÊTRE). Phytomedicine. 2011; 18 (12): 1037-1044.2183162023. Mehrzadi S, Tavakolifar B, Huseini HF, Mosavat SH, Heydari M. L&#39;efficacité de Boswellia serrata gomme de résine pour le contrôle du profil lipidique et de la glycémie chez les patients diabétiques. Iran J Med Sci. 2016; 41 (3): S66.2751669624. Schrott E, S Laufer, Lämmerhofer M, Ammon HP. Extrait de résine de gomme de Boswellia serrata diminue les anticorps anti-IA (2) chez un patient présentant un «diabète auto-immunitaire de l&#39;adulte à déclenchement tardif» (LADA). Phytomedicine. 2014; 21 (6): 786.2469844025. Safayhi H, ER Sailer, Ammon HP. Mécanisme d&#39;inhibition de la 5-lipoxygénase par l&#39;acide acétyl-11-céto-bêta-boswellique. Mol Pharmacol. 1995; 47 (6): 1212-1216,760346226. Singh GB, Atal CK. Pharmacologie d’un extrait de salai guggal extraitBoswellia serrata, un nouvel agent anti-inflammatoire non stéroïdien. Actions des agents. 1986; 18 (3-4): 407-412,375175227. Ammon HP, Safayhi H, Mack T, Sabieraj J. Mécanisme des actions anti-inflammatoires de la curcumine et des acides boswelliques. J Ethnopharmacol. 1993; 38 (2-3): 113-119,851045828. Ammon HP, Mack T, Singh GB, Safayhi H. Inhibition de la formation de leucotriènes B4 dans les neutrophiles péritonéaux de rat par un extrait éthanolique de l&#39;exsudat de résine de gomme Boswellia serrata. Planta Med. 1991; 57 (3): 203-207.165457529. Safayhi H, Mack T, J Sabieraj, MI Anazodo, LR subramanien, Ammon HP. Acides boswelliques: nouveaux inhibiteurs spécifiques de la 5-lipoxygénase non-rédox. J Pharmacol Exp Ther. 1992; 261 (3): 1143-1146.160237930. Kiela PR, Midura AJ, Kuscuoglu N, et al. Les effets de Boswellia serrata dans des modèles murins de colite induite chimiquement. Am J Physiol Gastrointest Foie Physiol. 2005; 288 (4): G798-G808.1553943331. Singh S, Khajuria A, SC Taneja, et al. L&#39;effet protecteur de l&#39;ulcère gastrique des acides boswelliques, un inhibiteur des leucotriènes de Boswellia serratachez les rats. Phytomédecine. 2008; 15 (6-7): 408-415.1842401932. Hartmann RM, Fillmann HS, Martins MI, Meurer L, NP Marroni. Boswellia serrata possède des propriétés anti-inflammatoires et antioxydantes bénéfiques dans un modèle de colite expérimentale. Phytother Res. 2014; 28 (9): 1392-1398.2461953833. Gupta I, Parihar A, Malhotra P, et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res. 1997;2(1):37-43.904959334. Pellegrini L, Milano E, Franceschi F, et al. Managing ulcerative colitis in remission phase: usefulness of Casperome, an innovative lecithin-based delivery system of Boswellia serrata extract. Eur Rev Med Pharmacol Sci. 2016;20(12):2695-2700.2738332535. Rahimi R, Nikfar S, Abdollahi M. Induction of clinical response and remission of inflammatory bowel disease by use of herbal medicines: a meta-analysis. World J Gastroenterol. 2013;19(34):5738-5749.2403937036. Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: A Cochrane inflammatory bowel disease and function bowel disorders review group systematic review of randomized trials. Am J Gastroenterol. 2009;104(1):235-241.1909887537. Madisch A, Miehlke S, Eichele O, et al. Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial. Int J Colorectal Dis. 2007;22(12):1445-1451.1776401338. Chande N, McDonald JW, MacDonald JK. Interventions for treating collagenous colitis. Cochrane Database Syst Rev. 2008;(2):CD003575.1842589239. Gerhardt H, Seifert F, Buvari P, Vogelsang H, Repges R. Therapy of active Crohn disease with Boswellia serrata extract H 15. Z Gastroenterol (German). 2001;39(1):11-17.1121535740. Holtmeier W, Zeuzem S, Preiss J, et al. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn&#39;s disease: good safety profile but lack of efficacy. Inflamm Bowel Dis. 2011;17(2):573-582.2084852741. Gupta I, Parihar A, Malhotra P, et al. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med. 2001;67(5):391-395.1148844942. Khosravi Samani M, Mahmoodian H, Moghadamnia A, Poorsattar Bejeh Mir A, Chitsazan M. The effect of Frankincense in the treatment of moderate plaque-induced gingivitis: a double blinded randomized clinical trial. Daru. 2011;19(4):288-294.2261567143. Prabhavathi K, Chandra US, Soanker R, Rani PU. A randomized, double blind, placebo controlled, cross over study to evaluate the analgesic activity of Boswellia serrata in healthy volunteers using mechanical pain model. Indian J Pharmacol. 2014;46(5):475-479.2529857344. Cameron M, Chrubasik S. Oral herbal therapies for treating osteoarthritis. Cochrane Database Syst Rev. 2014;(5):CD002947.2484873245. Kulkarni RR, Patki PS, Jog VP, Gandage SG, Patwardnan B. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol. 1991;33(1-2):91-95.194318046. Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee—a randomized double blind placebo controlled trial. Phytomedicine. 2003;10(1):3-7.1262245747. Sontakke S, Thawani V, Pimpalkhute S, Kabra P, Babhulkar S, Hingorani L. Open, randomized, controlled clinical trial of Boswellia serrata extract as compared to valdecoxib in osteoarthritis of knee. Indian J Pharmacol. 2007;39:27-29.48. Vishal AA, Mishra A, Raychaudhuri SP. A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee. Int J Med Sci. 2011;8(7):615-622.2202221449. Sengupta K, Alluri KV, Satish AR, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther. 2008;10(4):R85.1866705450. Franceschi F, Togni S, Belcaro G, et al. A novel lecithin based delivery form of Boswellic acids (Casperome) for the management of osteo-muscular pain: A registry study in young rugby players. Eur Rev Med Pharmacol Sci. 2016;20(19):4156-4161.2777578051. Etzel R. Special extract of Boswellia serrata (H 15) in the treatment of rheumatoid arthritis. Phytomedicine. 1996;3(1):91-94.2319487052. Lampl C, Haider B, Schweiger C. Long-term efficacy of Boswellia serrata in four patients with chronic cluster headache. Cephalalgia. 2012;32(9):719-722.2276796253. Raja AF, Ali F, Khan IA, Shawl AS, Arora DS. Acetyl-11-keto-β-boswellic acid (AKBA); targeting oral cavity pathogens. BMC Res Notes. 2011;4:406.2199243954. Schmidt TJ, Kaiser M, Brun R. Complete structural assignment of serratol, a cembrane-type diterpene from Boswellia serrata, and evaluation of its antiprotozoal activity. Planta Med. 2011;77(8):849-850.2115768655. Sadhasivam S, Palanivel S, Ghosh S. Synergistic antimicrobial activity of Boswellia serrata Roxb. ex Colebr. (Burseraceae) essential oil with various azoles against pathogens associated with skin, scalp and nail infections. Lett Appl Microbiol. 2016;63(6):495-501.2773065856. Badria FA, Mohammed EA, El-Badrawy MK, El-Desouky M. Natural leukotriene inhibitor from Boswellia: A potential new alternative for treating bronchial asthma. Altern Complement Ther. 2004;10:257-265.57. Clark CE, Arnold E, Lasserson TJ, Wu T. Herbal interventions for chronic asthma in adults and children: a systematic review and meta-analysis. Prim Care Respir J. 2010;19(4):307-314.2064038858. Gupta I, Gupta V, Parihar A, et al. Effects of Boswellia serrata gum resin in patient with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res. 1998;3(11):511-514.981003059. Calzavara-Pinton P, Zane C, Facchinetti E, Capezzera R, Pedretti A. Topical boswellic acids for treatment of photoaged skin. Dermatol Ther. 2010;23(suppl 1):S28-S32.2013691960. Pedretti A, Capezzera R, Zane C, Facchinetti E, Calzavara-Pinton P. Effects of topical boswellic acid on photo and age-damaged skin: clinical, biophysical, and echographic evaluations in a double-blind, randomized, split-face study. Planta Med. 2010;76(6):555-560.1991871261. Togni S, Maramaldi G, Bonetta A, Giacomelli L, Di Pierro F. Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial. Eur Rev Med Pharmacol Sci. 2015;19(8):1338-1344.2596770662. Togni S, Maramaldi G, Di Pierro F, Biondi M. A cosmeceutical formulation based on boswellic acids for the treatment of erythematous eczema and psoriasis. Clin Cosmet Investig Dermatol. 2014;7:321-327.2541915363. Pungle P, Banavalikar M, Suthar A, Biyani M, Mengi S. Immunomodulatory activity of boswellic acids of Boswellia serrata Roxb. Indian J Exp Biol. 2003;41(12):1460-1462.1532050364. Kapil A, Moza N. Anticomplementary activity of boswellic acids—an inhibitor of C3-convertase of the classical complement pathway. Int J Immunopharmacol. 1992;14(7):1139-1143.145239965. Barrett JT. Textbook of Immunology. 4th ed. St Louis, MO: CV Mosby Company; 1983:177.66. Mahmoud MF, Diaai AA, Ahmed F. Evaluation of the efficacy of ginger, Arabic gum, and Boswellia in acute and chronic renal failure. Ren Fail. 2012;34(1):73-82.2201761967. Moreillon JJ, Bowden RG, Deike E, et al. The use of an anti-inflammatory supplement in patients with chronic kidney disease. J Complement Integr Med. 2013;10.2382832968. Arkalgud Rangaswamy P, Sultana A, Rahman K, Nagapattinam S. Efficacy of Boswellia serrata L. and Cyperus scariosus L. plus pelvic floor muscle training in stress incontinence in women of reproductive age. Complement Ther Clin Pract. 2014;20(4):230-236.2522515169. Galeone G, Spadavecchia R, Balducci MT, Pagliarulo V. The role of Proxelan in the treatment of chronic prostatitis. Results of a randomized trial. Minerva Urol Nefrol (Italian). 2012;64(2):135-141.2261730770. Wang M, Chen M, Ding Y, et al. Pretreatment with β-boswellic acid improves blood stasis induced endothelial dysfunction: role of eNOS activation. Sci Rep. 2015;5:15357.2648200871. Dahmen U, Gu YL, Dirsch O, et al. Boswellic acid, a potent antiinflammatory drug, inhibits rejection to the same extent as high dose steroids. Transplant Proc. 2001;33(1-2):539-541.1126694772. Sterk V, Büchele B, Simmet T. Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers. Planta Med. 2004;70(12):1155-1160.1564355073. Weber CC, Reising K, Müller WE, Schubert-Zsilavecz M, Abdel-Tawab M. Modulation of Pgp function by boswellic acids. Planta Med. 2006;72(6):507-513.1677353474. Milić N, Milosević N, Golocorbin Kon S, Bozić T, Abenavoli L, Borrelli F. Warfarin interactions with medicinal herbs. Nat Prod Commun. 2014;9(8):1211-1216.2523360775. Gummi Boswellii. In: WHO Monographs on Selected Medicinal Plants. Vol. 4. Geneva, Switzerland: World Health Organization; 2009:48-60.76. Abdel-Tawab M, Werz O, Schubert-Zsilavecz M. Boswellia serrata: An overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet. 2011;50(6):349-369.2155393177. Ammon HP. Boswellic acids in chronic inflammatory diseases. Planta Med. 2006;72(12):1100-1116.1702458878. Singh GB, Bani S, Singh S. Toxicity and safety evaluation of boswellic acids. Phytomedicine. 1996;3(1):87-90.2319486979. Krishnaraju AV, Sundararaju D, Vamsikrishna U, et al. Safety and toxicological evaluation of Aflapin: A novel Boswellia-derived anti-inflammatory product. Toxicol Mech Methods. 2010;20(9):556-563.2087466480. Dey D, Chaskar S, Athavale N, Chitre D. Acute and chronic toxicity, cytochrome P450 enzyme inhibition, and hERG channel blockade studies with a polyherbal, ayurvedic formulation for inflammation. Biomed Res Int. 2015;2015:971982.25893199


This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Incense, Indian uses, benefits and dosage | DISCOUNT CODE !
4.9 (99%) 39 votes

Leave a Reply